Study of the Efficacy and Safety of Alirocumab (REGN727/SAR236553) in Combination With Other Lipid-modifying Treatment (LMT) (ODYSSEY OPTIONS I)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 355 participants.

Also called NCT01730040

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 355 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01730040
Other papers using this trial's data
  • Alirocumab as Add-On to Atorvastatin Versus Other Lipid Treatment Strategies: ODYSSEY OPTIONS I Randomized Trial The Journal of clinical endocrinology and metabolism, 2015-08 DOI, PubMed 26030325, PMC4524987 Not in the PMC Open Access subset.

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Australia, Canada, France, Germany, Italy, Mexico, Spain, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01730040. Randomized; quadruple masking; primary purpose treatment. Start 2012-10 (registry gives no type); primary completion 2014-04 (actual). Results posted on 2015-08-31.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Study of the Efficacy and Safety of Alirocumab (REGN727/SAR236553) in Combination With Other Lipid-modifying Treatment (LMT) (ODYSSEY OPTIONS I)
Condition
Hypercholesterolemia
Intervention (Drug)
Alirocumab
Intervention (Drug)
Atorvastatin
Intervention (Drug)
Ezetimibe
Intervention (Drug)
Rosuvastatin
Intervention (Drug)
Placebo
Lead sponsor
Regeneron Pharmaceuticals (class: industry)
Collaborator
Sanofi (class: industry)

Record details

Record id
cardio:ct-nct01730040
Content hash
a6098a9789592deb0a3ab2a4d4e305de7cbf454123aefceeb5489f8519bcb525